Evidence map›Paper›PMID 35421371›Full record

ArticleDevelopmental cell2022

VAP-A and its binding partner CERT drive biogenesis of RNA-containing extracellular vesicles at ER membrane contact sites.

Bahnisikha Barman, Bong Hwan Sung, Evan Krystofiak, Jie Ping, Marisol Ramirez, Bryan Millis, Ryan Allen, Nripesh Prasad, Sergei Chetyrkin, M Wade Calcutt and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Pseudouridine selects RNAs for extracellular transport.bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Bahnisikha BarmanDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Bong Hwan SungDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Evan KrystofiakVanderbilt University Cell Imaging Shared Resource, Nashville, TN, USA.
Jie PingDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Marisol RamirezDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Bryan MillisDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Biomedical Engineering, Vanderbilt Biophotonics Center, Vanderbilt School of Engineering, Nashville, TN, USA.
Ryan AllenDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Nripesh PrasadHudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
Sergei ChetyrkinMass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA.
M Wade CalcuttMass Spectrometry Research Center, Vanderbilt University, Nashville, TN, USA; Department of Biochemistry, Vanderbilt University, Nashville, TN, USA.
Kasey VickersDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
James G PattonDepartment of Biological Sciences, Vanderbilt University, Nashville, TN, USA.
Qi LiuDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Alissa M WeaverDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: alissa.weaver@vanderbilt.edu.
Vanderbilt University · USVanderbilt University Medical Center · USHudsonAlpha Institute for Biotechnology · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LINTON, MACRAE F · 2014 to 2025
$24.7M
Roles for Supermeres in CRC ProgressionP01CA229123 · NCI · VANDERBILT UNIVERSITY · PI Alissa M Weaver · 2020 to 2026
$12.9M
Trafficking of eRNAs in K-Ras Mutant Colon CancerU19CA179514 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2013 to 2017
$5.3M
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted TherapyR01CA260958 · NCI · VANDERBILT UNIVERSITY · PI COOK, REBECCA SARA, DUVALL, CRAIG LEWIS · 2021 to 2025
$3.0M
High resolution Thermo Scientific Q-Exactive Orbitrap mass spectrometer for metabolomicsS10OD023514 · OD · VANDERBILT UNIVERSITY · PI SCHEY, KEVIN L · 2017 to 2017
$524k
NCATS NIH HHS UL1 TR002243NCI NIH HHS P01 CA229123NCI NIH HHS R01 CA260958NCI NIH HHS U19 CA179514NCRR NIH HHS UL1 RR024975NHLBI NIH HHS P01 HL116263NIH HHS S10 OD023514
6 · The paper itself

Abstract

RNA transfer via extracellular vesicles (EVs) influences cell phenotypes; however, lack of information regarding biogenesis of RNA-containing EVs has limited progress in the field. Here, we identify endoplasmic reticulum membrane contact sites (ER MCSs) as platforms for the generation of RNA-containing EVs. We identify a subpopulation of small EVs that is highly enriched in RNA and regulated by the ER MCS linker protein VAP-A. Functionally, VAP-A-regulated EVs are critical for miR-100 transfer between cells and in vivo tumor formation. Lipid analysis of VAP-A-knockdown EVs revealed reductions in the EV biogenesis lipid ceramide. Knockdown of the VAP-A-binding ceramide transfer protein CERT led to similar defects in EV RNA content. Imaging experiments revealed that VAP-A promotes luminal filling of multivesicular bodies (MVBs), CERT localizes to MVBs, and the ceramide-generating enzyme neutral sphingomyelinase 2 colocalizes with VAP-A-positive ER. We propose that ceramide transfer via VAP-A-CERT linkages drives the biogenesis of a select RNA-containing EV population.

Indexed as

Extracellular VesiclesGolgi ApparatusCeramidesEndoplasmic ReticulumProtein Serine-Threonine KinasesRNACeramidesProtein Serine-Threonine KinasesRNAceramidecolon cancerER membrane contact sitesexosomesextracellular RNAextracellular vesiclesmiRNARNA-binding proteinsVAP-A

Identifiers

PMID35421371
PMCPMC9075344
OpenAlexW4223977854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.